Skip to main content
. 2024 Jul 15;10:42. doi: 10.1186/s40959-024-00245-x

Table 3.

Comparison of nilotinib total daily dose at the time of CV event against the total daily dose of nilotinib at the time of last follow-up or cessation in patients without a CV event

End points No Event (mg) CV event (mg) p-value

Any CV event

(median, IQR)

450 (400–600) 600 (437.5–800) 0.0074

Ischaemic event

(median, IQR)

500 (400–600) 600 (600–800) 0.0118

CV = cardiovascular